EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging roles of the cGAS/STING pathway in cardiovascular diseases

Wataru Saitoh, Yasutomi Higashikuni, Oyunbileg Bavuu, Masataka Sata, Daiju Fukuda

Journal of Clinical Investigation · 01.07.2026 · 136 (13)

DOI: 10.1172/jci204551 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.07.2026. Verfasst von Wataru Saitoh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Cardiovascular Diseases, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide, highlighting the need for novel therapeutic approaches. Inflammation plays a key role in CVD pathogenesis, and accumulating evidence has implicated the cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway in this process. The cGAS/STING pathway recognizes both non-self- and self-DNA, including mitochondrial and nuclear DNA, to activate its downstream proinflammatory signaling molecules, including TANK-binding kinase 1, IFN regulatory factor 3, and NF-κB. Various pathological stressors have been shown to induce self-DNA release into the cytosol and bloodstream from damaged cells in the cardiovascular system, indicating that circulating cell-free DNA is a useful biomarker of CVDs; however, how this contributes to the inflammatory signaling, cell death, and fibrosis that characterize CVDs remains unclear. Here, we discuss the current understanding on the roles of self-DNA and the cGAS/STING pathway in the pathophysiology of CVDs and the therapeutic potential of targeting this pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesMembrane ProteinsCardiovascular DiseasesSignal TransductionHumansSTING ProteincGAS-STING Signaling PathwayCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseAnimalsNF-kappa BProtein Serine-Threonine KinasesInterferon Regulatory Factor-3Inflammation

Substanzen

NucleotidyltransferasesMembrane ProteinsSTING ProteincGAS protein, humanSTING1 protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseNF-kappa BProtein Serine-Threonine KinasesInterferon Regulatory Factor-3

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Division of Cardiovascular and Genetic Research, Center for Molecular Medicine, and.
  • Department of Cardiovascular Medicine, Jichi Medical University, Tochigi, Japan.
  • Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Cardiovascular Medicine, Tokushima University Graduate School, Tokushima, Japan.

Zitieren

APA

Saitoh, W., Higashikuni, Y., Bavuu, O., Sata, M., & Fukuda, D. (2026). Emerging roles of the cGAS/STING pathway in cardiovascular diseases. Journal of Clinical Investigation, 136(13). https://doi.org/10.1172/jci204551

Vancouver

Saitoh W, Higashikuni Y, Bavuu O, Sata M, Fukuda D. Emerging roles of the cGAS/STING pathway in cardiovascular diseases. Journal of Clinical Investigation. 2026;136(13). doi:10.1172/jci204551

BibTeX
@article{Saitoh2026,
  author = {Saitoh, Wataru and Higashikuni, Yasutomi and Bavuu, Oyunbileg and Sata, Masataka and Fukuda, Daiju},
  title = {Emerging roles of the cGAS/STING pathway in cardiovascular diseases},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {13},
  doi = {10.1172/jci204551}
}
Kostenlos starten →